The role of sonication in the microbiological diagnosis of implant-associated infections – the experience of the National Institute for Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest
- Raluca Mihăilescu1Email author,
- Daniela Tălăpan1,
- Olga Dorobăț1,
- Alexandru Rafila1, 2,
- Emilia Capraru1,
- Daniela Munteanu1,
- Anca Streinu-Cercel1, 2,
- Oana Streinu-Cercel1, 2,
- Vlad Predescu2, 3,
- Florian Purghel2, 4,
- Cătălin Cârstoiu2, 5,
- Razvan Ene2, 5,
- Dana Mihaela Jianu2, 6,
- Cristina Popescu1, 2,
- Victoria Aramă1, 2 and
- Adrian Streinu-Cercel1, 2
© Mihăilescu et al; licensee BioMed Central Ltd. 2013
Published: 16 December 2013
Sonication optimizes the microbiological diagnosis of implant-associated infections. It is recommended in international guidelines of Infectious Diseases, but not yet worldwide accessible. In Romania, sonication of medical implants was first introduced in 2012 in the National Institute for Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest.
We present the status report on sonication of medical implants in Bucharest, Romania during 2012 and 2013.
We processed 10 joint prostheses sent by three departments of orthopedics and 7 breast implants from one center of plastic surgery in Bucharest. Sonication of the prostheses revealed either monomicrobial infections: Parvimonas micra, Burkholderia cepacia (n=4), Serratia marcescens, Staphylococcus warneri or polymicrobial infections: Burkholderia cepacia and Staphylococcus aureus (n=2); Pseudomonas aeruginosa, Klebsiella pneumoniae ESBL+ and Enterococcus faecium. Mammary implants were screened, but all were found culture-negative.
We also present the first case of sonication – a polymicrobial infection with methicillin resistant Staphylococcus aureus and Burkholderia cepacia. B cepacia was susceptible to piperacillin ± tazobactam, ceftazidime, meropenem, co-trimoxazole. The patient received vancomycin i.v. 500 mg Q6h + co-trimoxazole 400/80 mg 2tb Q8h p.o. + ceftazidime 2g Q8h i.v. for 6 weeks and was then switched to ciprofloxacin 750 mg Q12h + co-trimoxazol 2tb Q8h p.o. for a total of 5 months. As CRP remained around 25 mg/L, a synovial puncture was requested. The synovial fluid was culture-negative and the synovial leucocyte count was within the normal range. Subsequently, revision arthroplasty was performed, with favorable outcome.
Sonication is a key tool for the accurate microbiological diagnosis of implant-associated infections, dislodging the biofilm-forming microbes from the implant surface. It is helpful even if the infection is polymicrobial. It also revealed nosocomial infections which needed further epidemiological measures. A multidisciplinary approach (microbiology, infectious diseases and surgery) is essential for the management of implant-associated infections.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.